Anbio Biotechnology Class A Ordinary Shares (NNNN) vs Pro-Dex, Inc. (PDEX)
A side-by-side comparison of Anbio Biotechnology Class A Ordinary Shares and Pro-Dex, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NNNN
Anbio Biotechnology Class A Ordinary Shares
$4.79HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
PDEX
Pro-Dex, Inc.
$65.34HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — NNNN vs PDEX
growth of $100 · dividends reinvested · last 2yNNNN -16.3% (-8.5%/yr)PDEX +80.8% (+34.5%/yr)PDEX compounded faster over this window
NNNN PDEX
NNNN vs PDEX: by the numbers
- •NNNN is the larger company ($210M vs $209M market cap).
- •NNNN converts more revenue to profit (74.06% vs 17.62% net margin).
Metrics side by side
Valuation
| Metric | NNNN | PDEX |
|---|---|---|
| P/E ratio | N/A | 15.86 |
| Forward P/E | N/A | 21.15 |
| PEG ratio | N/A | 0.54 |
| P/S ratio | N/A | 2.69 |
| P/B ratio | 6.97 | 4.38 |
| EV / EBITDA | N/A | 15.19 |
| FCF yield | N/A | 3.30% |
Profitability
| Metric | NNNN | PDEX |
|---|---|---|
| Gross margin | 87.24% | 31.38% |
| Operating margin | 66.70% | 16.75% |
| Net margin | 74.06% | 17.62% |
| ROE | 21.24% | 28.68% |
| ROIC | 19.13% | 14.99% |
Growth (annualized)
| Metric | NNNN | PDEX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 15.32% |
| EPS CAGR (5Y) | N/A | 29.38% |
| Total return CAGR (5Y) | N/A | 20.45% |
Frequently asked
- Is NNNN or PDEX more profitable?
- NNNN runs the higher net margin — NNNN at 74.06% versus PDEX at 17.62%.
Go deeper
Dig into the metrics
Pro-Dex P/E ratioAnbio Biotechnology Class A Ordinary Shares ROEPro-Dex ROEAnbio Biotechnology Class A Ordinary Shares operating marginPro-Dex operating marginAnbio Biotechnology Class A Ordinary Shares revenue growthPro-Dex revenue growthAnbio Biotechnology Class A Ordinary Shares free cash flowPro-Dex free cash flow
Anbio Biotechnology Class A Ordinary Shares & Pro-Dex appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.